CFTR and cystic fibrosis: ARN23765 is a CFTR corrector molecule developed as part of the Task Force for Cystic Fibrosis (TFCF) project, a strategic initiative funded by the Fondazione Italiana per la Ricerca in Fibrosi Cistica (FFC) in collaboration with the Istituto Italiano di Tecnologia (IIT).